Is unreliable point-of-care urine collection putting women on the front line of antimicrobial resistance?

Tuesday March 17th, 2026 - 12pm ET, 4pm GMT, 5pm CET

Unreliability of female urine specimens leads to unnecessary prescribing, calling for a protocol for midstream urine collection.
Why is urine not treated like blood? Female urinary tract, bladder or kidney infections are commonly diagnosed using a urine sample, recommended to be midstream because the first void can be contaminated by bacteria, flora and debris from the skin. Guideline collection is challenging for clinicians to explain and women to perform.

Up to 30% contamination creates false-positive dips and empirical broad spectrum prescribing – or failed lab analysis due to mixed growth. Diagnosing UTI early is challenging when urine collection is left to chance and patient intervention. Women do not need antibiotic over prescribing – they need reliable specimen collection.

What you will learn

  • We will present shocking stats and data around already resistant UTI bacteria, and ask why broad-spectrum antibiotics are still being prescribed so heavily.
  • Pharmacy First will prescribe based on two verbal symptoms alone, with no diagnostic test to guide targeted medication.

Of interest to
All those involved in women’s health, diagnostics, AMR, primary care, labs, and maternity.

Speakers

Giovanna Forte

CEO, Forte Medical Limited

Peezy Midstream won a Medical Innovation Award in 2002. The inventor was my brother Dr Vincent Forte, a primary care clinician of over 20 years. Vincent asked me to assist with device commercialization. I ran 10 years of R&D, successful clinical trials and evidence-generation, regulatory work, investment generation, patent and marketing activity with subsequent sales growth across the UK and USA. I am recognized not only for the pioneering impact I’ve made in FemTech through entrepreneurship, public speaking and awards but also for my long-term vision and ability to overcome challenges with positive outlook… known as Forte-tude.

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with